Buscar
Mostrando ítems 1-10 de 363
Biosimilar monoclonal antibodies in Latin America
(IntechOpen, 2021)
Antibodies, also known as immunoglobulins, are complex glycoproteins produced by B-cells against foreign substances as part of the adaptive immune response [1, 2]. The invention of the hybridoma technology in 1975 by Köhler ...
Monoclonal Antibody Therapeutics As Potential Interferences On Protein Electrophoresis And Immunofixation
(WALTER DE GRUYTER GMBHBERLIN, 2016)
Development of a workflow for therapeutic antibody characterization by LC-MS/MS
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2023)
Updates on the production of therapeutic antibodies using human hybridoma technique
(Bentham Science Publishers, 2016)
Patentability of monoclonal antibodies in Brazil: analysis of non-obviousness requirement
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2019)
Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals
(Universidade de São Paulo, Faculdade de Ciências Farmacêuticas, 2011)
Monoclonal antibodies represent the fastest growing class of biopharmaceutical products and have a host of applications in medical research, diagnosis, therapy, and basic science. The production of recombinant monoclonal ...
Monoclonal antibodies carried in drug delivery nanosystems as a strategy for cancer treatment
(2021-01-01)
Monoclonal antibodies carried in nanosystems have been extensively studied and reported as a promising tool for the treatment of various types of cancers. Monoclonal antibodies have great advantages for the treatment of ...
Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis
(Expert Reviews, 2008-07-01)
This review discusses some of the impacts that biotechnology, genomics and nanotechnology convergence should have on future cancer management, in particular, the development of innovative diagnostic and therapeutic approaches ...
Uso del rituximab(anticuerpo monoclonal anti-CD20) en lupus eritematoso sistémico refractario a tratamiento: Caso clínico
(Sociedad Médica de Santiago, 2005)
Genetic engineering of antibody molecules
(Wiley VCH Verlag, 2015)
Antibodies are proteins produced by the immune system to combat pathogens and have long been appreciated for their exquisite specificity. The development of the hybridoma technology made it possible to immortalize single ...